Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Introduction

Cancer is currently considered the leading reason of death globally and the danger of this disease is rising daily, especially after the major life-threatening side effects caused by synthetic drugs used for the treatment of cancer. Thus, the reliance on medicinal plants that have been used over the years for the management of cancer becomes crucial. Family Rubiaceae have been used in traditional medicine for treating various ailments being rich in secondary metabolites such as flavonoids, triterpenoids, alkaloids, volatile components, glycosides, and phenols.

Objective

Based on the wide anticancer data reported on plants belonging to this family, compared to plant species from other families, it was aimed to present this review focusing mainly on the anticancer bioactive compounds in each plant species, the type of cancer cell inhibited, and the relative mechanism of activity.

Methods

Accordingly, we adopted an exhaustive literature review in journals and books published in databases such as ScienceDirect, Embase, Scopus, Academic Google Scholar, Scientific Electronic Library Online (SciELO), Web of Science, and Medline from 1995 to 2024.

Results and Discussion

The results revealed that plants from the Family Rubiaceae are rich in bioactive compounds of wide anticancer potential such as alkaloids, flavonoids, polyphenols, triterpenes, saponins, tannins, and quinones. The major anticancer actions were cytotoxic, apoptotic, antiproliferative, cytostatic, antimetastatic, and antioxidative as well as inhibition of angiogenesis, reduction of cancer cell viability, and cell cycle arrest.

Conclusion

This work may be the cornerstone for researchers to focus on the ongoing discovery of new anticancer drugs based on plants from the family Rubiaceae and it may encourage further in-depth and clinical trials in the future, to elucidate the anticancer efficacy and safety of these medicinal plants.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072373736250412081850
2025-04-24
2026-03-11

  • From This Site

    /content/journals/cbc/10.2174/0115734072373736250412081850
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. DesaiA. QaziG. GanjuR. El-TamerM. SinghJ. SaxenaA. BediY. TanejaS. BhatH. Medicinal plants and cancer chemoprevention.Curr. Drug Metab.20089758159110.2174/138920008785821657 18781909
     [Google Scholar]
  2. OhiaguF.O. ChikezieP.C. ChikezieC.M. EnyohC.E. Anticancer activity of Nigerian medicinal plants: A review.Future J. Pharm. Sci.2021717010.1186/s43094‑021‑00222‑6
     [Google Scholar]
  3. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.21492 30207593
     [Google Scholar]
  4. ChandraS. GahlotM. ChoudharyA.N. PalaiS. de AlmeidaR.S. de VasconcelosJ.E.L. dos SantosF.A.V. de FariasP.A.M. CoutinhoH.D.M. Scientific evidences of anticancer potential of medicinal plants.Food Chem. Adv.2023210023910.1016/j.focha.2023.100239
     [Google Scholar]
  5. Pledgie-TracyA. SobolewskiM.D. DavidsonN.E. Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines.Mol. Cancer Ther.2007631013102110.1158/1535‑7163.MCT‑06‑0494 17339367
     [Google Scholar]
  6. Ali KansoM. Ali HijaziM. El-LakanyA. Aboul-ElaM. Review on phytochemical constituents and pharmacological activities of genus Galium.J. Appl. Pharm. Sci.202414909605610.7324/JAPS.2024.195572
     [Google Scholar]
  7. HeitzmanM.E. NetoC.C. WiniarzE. VaisbergA.J. HammondG.B. Ethnobotany, phytochemistry and pharmacology of (Rubiaceae).Phytochemistry200566152910.1016/j.phytochem.2004.10.022 15649507
     [Google Scholar]
  8. MartinsD. NunezC. Secondary metabolites from Rubiaceae species.Molecules2015207134221349510.3390/molecules200713422 26205062
     [Google Scholar]
  9. SandersJ.P. DawsonW.T. Efficacy of quinidine in malaria.J. Am. Med. Assoc.193299211773177710.1001/jama.1932.02740730037010
     [Google Scholar]
  10. Aboul-ElaM.A. KamalS.A. BadrJ.M. Growing in Egypt.Alex. J. Pharm. Sci.200620279
     [Google Scholar]
  11. El-LakanyA.M. Aboul-ElaM.A. Abdel-KaderM.S. BadrJ.M. SabriN.N. GoherY. Anthraquinones with antibacterial activities from Crucianella maritima L. growing in Egypt.Nat. Prod. Sci.20041026368
     [Google Scholar]
  12. RobbrechtE. Tropical woody Rubiaceae.Opera Botanica Belgica.19881272599602
     [Google Scholar]
  13. JudkevichM.D. SalasR.M. GonzalezA.M. Anatomy and development of the edible fruits of Cordiera concolor (Rubiaceae).An. Acad. Bras. Cienc.2022943e2021007110.1590/0001‑3765202220210071 35920486
     [Google Scholar]
  14. BremerB. ErikssonT. Time tree of Rubiaceae: Phylogeny and dating the family, subfamilies, and tribes.Int. J. Plant Sci.2009170676679310.1086/599077
     [Google Scholar]
  15. DelpreteP.G. JardimJ.G. Systematics, taxonomy and floristics of Brazilian Rubiaceae: An overview about the current status and future challenges.Rodriguésia201263110112810.1590/S2175‑78602012000100009
     [Google Scholar]
  16. DurodolaJ. Anti-neoplastic property of a crystalline compound extracted from Morinda lucida.Planta Med.197426720821110.1055/s‑0028‑1099378 4427954
     [Google Scholar]
  17. Appiah-OpongR. TuffourI. AnnorG.K. DorisA. Blankson-DarkuP.C. Kissi-TwumA.A. Antiproliferative, antioxidant activities and apoptosis induction by Morinda lucida and Taraxacum officinale in human HL-60 leukemia cells.J. Global Biosci.20165742814291
     [Google Scholar]
  18. OhtaT. TilkanontT. AyerteyF. NakagawaM. TungN.H. BolahP. BlagogeeH.Jnr AppiahA.A. OclooA. OhashiM. TanoueK. YamaguchiY. OhtaN. YamaokaS. IwanagaS. UtoT. ShoyamaY. Establishment of a quantitative and qualitative analysis and isolation method for tetracyclic iridoids from Morinda lucida Bentham leaves.J. Pharm. Biomed. Anal.201916447548010.1016/j.jpba.2018.10.044 30472581
     [Google Scholar]
  19. CimangaR.K. TonaG.L. MesiaG.K. KambuO.K. BakanaD.P. KalendaP.D.T. PengeA.O. MuyembeJ-J.T. TottéJ. PietersL. VlietinckA.J. Bioassay-guided isolation of antimalarial triterpenoid acids from the leaves of Morinda lucida.Pharm. Biol.200644967768110.1080/13880200601009123
     [Google Scholar]
  20. PatelP.R. NagarA.A. PatelR.C. RathodD.K. PatelV.R. In-vitro anticancer activity of Rubia cordifolia against Hela and Hep-2 cell lines.Phytomedicine201024446
     [Google Scholar]
  21. BarlowR. BarnesD.A. CampbellA.M. NigamP.S. Owusu-ApentenR.K. Antioxidant, anticancer and antimicrobial, effects of Rubia cordifolia aqueous root extract.J. Adv. Biol. Biotech.2015511810.9734/JABB/2016/22625
     [Google Scholar]
  22. RoyA. AttreT. BharadvajaN. TiezziA. KarpińskiT.M. Anticancer agent from medicinal plants: A review. New Aspects in Medicinal Plants and PharmacognosyJBBooksPoznań, Poland2017154
     [Google Scholar]
  23. ChenH. ShangX. YuanH. NiuQ. ChenJ. LuoS. LiW. LiX. Total flavonoids of Oldenlandia diffusa (Willd.) Roxb. suppresses the growth of hepatocellular carcinoma through endoplasmic reticulum stress-mediated autophagy and apoptosis.Front. Pharmacol.202213101967010.3389/fphar.2022.1019670 36523497
     [Google Scholar]
  24. WillimottS. BarkerJ. JonesL.A. OparaE.I. Apoptotic effect of Oldenlandia diffusa on the leukaemic cell line HL60 and human lymphocytes.J. Ethnopharmacol.2007114329029910.1016/j.jep.2007.08.030 17936528
     [Google Scholar]
  25. KaurJ. KonarA. ChatterjeeR. SinghS. Review on the anti-cancerous properties of Oldenlandia diffusa Roxb.Int. J. Pharm. Pharm. Sci.202351010710.33545/27067009.2023.v5.i1a.79
     [Google Scholar]
  26. KangD.G. ParkS.J. ParkY.J. Target identification of Oldenlandia diffusa extract for anticancer property.Curr. Dev. Nutr.2021532910.1093/cdn/nzab037_039
     [Google Scholar]
  27. KhanT. AliM. KhanA. NisarP. JanS.A. AfridiS. ShinwariZ.K. Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects.Biomolecules20191014710.3390/biom10010047 31892257
     [Google Scholar]
  28. SiddiquiA.J. JahanS. SinghR. SaxenaJ. AshrafS.A. KhanA. ChoudharyR.K. BalakrishnanS. BadraouiR. BardakciF. AdnanM.M. Plants in anticancer drug discovery: From molecular mechanism to chemoprevention.BioMed Res. Int.202220221542548510.1155/2022/5425485 35281598
     [Google Scholar]
  29. ChenS.C. ZhaoX. YiR.K. QianJ. ShiY.H. WangR. Anticancer effects of Gardenia jasminoides in HepG2 human hepatoma cells.Biomed. Res.2017287716
     [Google Scholar]
  30. MaP. WuY. TaoL. HanJ. Effect of gardenia tea on apoptosis of human thyroid cancer cell line SW579 through PI3K-Akt pathway.Food Sci. Technol. (Campinas)202242e7312210.1590/fst.73122
     [Google Scholar]
  31. KimH.I. HongS.H. KuJ.M. KimM.J. JuS.W. ChangS.W. CheonC. KoS.G. Gardenia jasminoides enhances CDDP-induced apoptosis of glioblastoma cells via AKT/mTOR pathway while protecting death of astrocytes.Nutrients202012119610.3390/nu12010196 31936835
     [Google Scholar]
  32. RupachandraS. SaradaD.V.L. Induction of apoptotic effects of antiproliferative protein from the seeds of Borreria hispida on lung cancer (A549) and cervical cancer (HeLa) cell lines.BioMed Res. Int.2014201411810.1155/2014/179836 24605320
     [Google Scholar]
  33. NataruS. PulicherlaY. GaddalaB. A review on medicinal plants as a potential source for cancer.Int. J. Pharm. Sci. Rev. Res.2014261235248
     [Google Scholar]
  34. bhaskar, D.; Sathyamurthy, B. In vitro studies on the effect of Gardenia gummifera methanol extracts in MDA-MB-231cell lines 1Sandeep.J. Pharm. Sci.2017389298
     [Google Scholar]
  35. DwaraiS. SankunniL.M. Antiproliferative effects of the root bark of Gardenia gummifera L. f on HepG2 cell lines.Int. J. Pharm. Sci. Drug Res.2021202136137010.25004/IJPSDR.2021.130401
     [Google Scholar]
  36. UrdanibiaI. MichelangeliF. RuizM.C. MilanoB. TaylorP. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark.J. Ethnopharmacol.201315031154116210.1016/j.jep.2013.10.055 24212077
     [Google Scholar]
  37. PilarskiR. FilipB. WietrzykJ. KuraśM. GulewiczK. Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition.Phytomedicine201017141133113910.1016/j.phymed.2010.04.013 20576410
     [Google Scholar]
  38. Chanthira KumarH. LimX.Y. MohkiarF.H. SuhaimiS.N. Mohammad ShafieN. Chin TanT.Y. Efficacy and safety of Morinda citrifolia L. (noni) as a potential anticancer agent.Integr. Cancer Ther.2022211534735422113284810.1177/15347354221132848 36448674
     [Google Scholar]
  39. IqbalJ. AbbasiB.A. MahmoodT. KanwalS. AliB. ShahS.A. KhalilA.T. Plant-derived anticancer agents: A green anticancer approach.Asian Pac. J. Trop. Biomed.20177121129115010.1016/j.apjtb.2017.10.016
     [Google Scholar]
  40. RajivgandhiG. SaravananK. RamachandranG. LiJ.L. YinL. QueroF. AlharbiN.S. KadaikunnanS. KhaledJ.M. ManoharanN. LiW.J. Enhanced anti-cancer activity of chitosan loaded Morinda citrifolia essential oil against A549 human lung cancer cells.Int. J. Biol. Macromol.20201644010402110.1016/j.ijbiomac.2020.08.169 32853609
     [Google Scholar]
  41. GahtoriR. TripathiA.H. KumariA. NegiN. PaliwalA. TripathiP. JoshiP. RaiR.C. UpadhyayS.K. Anticancer plant-derivatives: Deciphering their oncopreventive and therapeutic potential in molecular terms.Future J. Pharm. Sci.2023911410.1186/s43094‑023‑00465‑5
     [Google Scholar]
  42. RibeiroA.F. SantosJ.F. MattosR.R. BarrosE.G.O. NasciuttiL.E. CabralL.M. SousaV.P.D. Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract.An. Acad. Bras. Cienc.2020921e2019033610.1590/0001‑3765202020190336 32321026
     [Google Scholar]
  43. UzorP.F. Recent developments on potential new applications of emetine as anti-cancer agent.EXCLI J.20161532332810.17179/excli2016‑280 27366142
     [Google Scholar]
  44. HariyantiH. MauludinR. SumirtapuraY.C. KurniatiN.F. A review: Pharmacological activities of quinoline alkaloid of Cinchona sp.Biointerface Res. Appl. Chem.202213431910.33263/BRIAC134.319
     [Google Scholar]
  45. ErnawatiT. Molecular docking simulation of Cinchona alkaloids derivatives to search new active anti-cancer agent.IJPST2019201996
     [Google Scholar]
  46. QiY. ZhaoX. ChenJ. PradiptaA.R. WeiJ. RuanH. ZhouL. HsungR.P. TanakaK. In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6.Biosci. Biotechnol. Biochem.20198361011102610.1080/09168451.2018.1559030 31074699
     [Google Scholar]
  47. IsahT. Anticancer alkaloids from trees: Development into drugs.Pharmacogn. Rev.20161020909910.4103/0973‑7847.194047 28082790
     [Google Scholar]
  48. GoryachaO.V. IlinaT.V. KovalevaA.M. Species of Galium l. Genus as promising anticancer agents.2021Available from: https://dspace.nuph.edu.ua/bitstream/123456789/25742/1/4-6.pdf
  49. RothenbergM.L. Topoisomerase I inhibitors: Review and update.Ann. Oncol.19978983785510.1023/A:1008270717294 9358934
     [Google Scholar]
  50. AlyS.H. ElbadryA.M. DoghishA.S. El-NasharH.A. Unveiling the pharmacological potential of plant triterpenoids in breast cancer management: An updated review.Naunyn Schmiedebergs Arch. Pharmacol.20243975571559610.1007/s00210‑024‑03054‑2
     [Google Scholar]
  51. WoźniakŁ. SkąpskaS. MarszałekK. Ursolic acid—a pentacyclic triterpenoid with a wide spectrum of pharmacological activities.Molecules20152011206142064110.3390/molecules201119721 26610440
     [Google Scholar]
  52. YinR. LiT. TianJ.X. XiP. LiuR.H. Ursolic acid, a potential anticancer compound for breast cancer therapy.Crit. Rev. Food Sci. Nutr.201858456857410.1080/10408398.2016.1203755 27469428
     [Google Scholar]
  53. KhwazaV. OyedejiO.O. AderibigbeB.A. Ursolic acid-based derivatives as potential anti-cancer agents: An update.Int. J. Mol. Sci.20202116592010.3390/ijms21165920 32824664
     [Google Scholar]
  54. MalikM.S. AlsantaliR.I. JassasR.S. AlsimareeA.A. SyedR. AlsharifM.A. KalpanaK. MoradM. AlthagafiI.I. AhmedS.A. Journey of anthraquinones as anticancer agents: A systematic review of recent literature.RSC Advances20211157358063582710.1039/D1RA05686G 35492773
     [Google Scholar]
  55. AzizM.Y. OmarA.R. SubramaniT. YeapS.K. HoW.Y. IsmailN.H. Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells.Oncol. Lett.2014751479148410.3892/ol.2014.1898
     [Google Scholar]
  56. LatifahS.Y. GopalsamyB. Abdul RahimR. Manaf AliA. Haji LajisN. Anticancer potential of damnacanthal and nordamnacanthal from Morinda elliptica roots on T-lymphoblastic leukemia cells.Molecules2021266155410.3390/molecules26061554 33808969
     [Google Scholar]
  57. LiR. LiH. LanJ. YangD. LinX. XuH. HanB. YangM. SuB. LiuF. JiangW. Damnacanthal isolated from Morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.Phytomedicine202210015408410.1016/j.phymed.2022.154084 35421676
     [Google Scholar]
  58. NualsanitT. RojanapanthuP. GritsanapanW. LeeS.H. LawsonD. BaekS.J. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.J. Nutr. Biochem.201223891592310.1016/j.jnutbio.2011.04.017 21852088
     [Google Scholar]
  59. García-VilasJ.A. QuesadaA.R. MedinaM.A. Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells.Sci. Rep.201551802110.1038/srep08021 25620570
     [Google Scholar]
  60. IshakN. Saiful YazanL. Haji LajisN. Nordamnacanthal induced apoptosis and mitotic-G2/M arrest with downregulation of Bcl-2 in the human breast cancer cell line (MCF-7).Med. Health Sci. J.201022273810.15208/mhsj.2010.20
     [Google Scholar]
  61. ImaiM. KikuchiH. DendaT. OhyamaK. HirobeC. ToyodaH. Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: A potential natural anti-cancer substance.Cancer Lett.20092761748010.1016/j.canlet.2008.10.036 19070422
     [Google Scholar]
  62. KopustinskieneD.M. JakstasV. SavickasA. BernatonieneJ. Flavonoids as anticancer agents.Nutrients202012245710.3390/nu12020457 32059369
     [Google Scholar]
  63. ÇetinkayaS. Taban AkçaK. SüntarI. Flavonoids and anticancer activity: Structure–activity relationship.Stud Nat. Prod. Chem.2022748111510.1016/B978‑0‑323‑91099‑6.00017‑7
     [Google Scholar]
  64. SaleemM. Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene.Cancer Lett.2009285210911510.1016/j.canlet.2009.04.033 19464787
     [Google Scholar]
  65. LiuK. ZhangX. XieL. DengM. ChenH. SongJ. LongJ. LiX. LuoJ. Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy.Pharmacol. Res.202116410537310.1016/j.phrs.2020.105373 33316380
     [Google Scholar]
  66. KuhtinskajaM. BraginaO. KulpM. VaherM. Anticancer effect of the iridoid glycoside fraction from Dipsacus fullonum L. leaves.Nat. Prod. Commun.202015910.1177/1934578X20951417
     [Google Scholar]
  67. NdongweT. WitikaB.A. MncwangiN.P. PokaM.S. SkosanaP.P. DemanaP.H. SummersB. Siwe-NoundouX. Iridoid derivatives as anticancer agents: An updated review from 1970-2022.Cancers (Basel)202315377010.3390/cancers15030770 36765728
     [Google Scholar]
  68. Abd-AllaH. SaadS. ShalabyN. AlyH. Abdel-MoeinN. AfifyA.E.M. AliH. A Review of iridoid glycosides content and their biological properties from Genus Citharexylum.Egypt. J. Chem.2024679456310.21608/ejchem.2024.272834.9391
     [Google Scholar]
  69. SuzukiM. TungN.H. KwofieK.D. AdegleR. Amoa-BosompemM. SakyiamahM. AyerteyF. OwusuK.B.A. TuffourI. AtchogloP. FrempongK.K. AnyanW.K. UtoT. MorinagaO. YamashitaT. AboagyeF. AppiahA.A. Appiah-OpongR. NyarkoA.K. YamaokaS. YamaguchiY. EdohD. KoramK. OhtaN. BoakyeD.A. AyiI. ShoyamaY. New anti-trypanosomal active tetracyclic iridoid isolated from Morinda lucida Benth.Bioorg. Med. Chem. Lett.201525153030303310.1016/j.bmcl.2015.05.003 26048790
     [Google Scholar]
  70. SaranyaK. ManivasaganV. GopiK. KarthikK. Broad-spectrum survey of medicinal plants as a potential source of anticancer agents.Bol. Latinoam. Caribe Plantas Med. Aromat.202221114010.37360/blacpma.22.21.1.01
     [Google Scholar]
  71. ThakurA. PrasadN. RainaK. SharmaR. ChaudharyA. Role of plant-based anticancer compounds in treatment of breast cancer.Curr. Pharmacol. Rep.20239646848810.1007/s40495‑023‑00335‑x
     [Google Scholar]
  72. MasalA.V. MoreJ.S. DhawareP.G. NarawdeD. KadamD. A review on natural anticancer herbal drugs.J. Pharmacogn. Phytochem.2022112298301
     [Google Scholar]
  73. AkhtarM.S. SwamyM.K. Anticancer plants: Properties and application.Springer201810.1007/978‑981‑10‑8548‑2
     [Google Scholar]
  74. Merillon, J.M.; Ramawat, K.G., Eds.; Co-evolution of secondary metabolites.Springer International Publishing2020
     [Google Scholar]
  75. BharadwajK.C. GuptaT. SinghR.M. Alkaloid group of Cinchona officinalis: Structural, synthetic, and medicinal aspects. Synthesis of Medicinal Agents from Plants.Elsevier201820522710.1016/B978‑0‑08‑102071‑5.00009‑X
     [Google Scholar]
  76. AkhtarM.S. SwamyM.K. Anticancer Plants: Mechanisms and Molecular Interactions.Springer201810.1007/978‑981‑10‑8417‑1
     [Google Scholar]
  77. AslantürkÖ. ÇelikT. KarabeyB. KarabeyF. Active phytochemical detecting, antioxidant, cytotoxic, apoptotic activities of ethyl acetate and methanol extracts of Galium aparine L.Br. J. Pharm. Res.201715611610.9734/BJPR/2017/32762
     [Google Scholar]
  78. LalremruatiM. LalmuansangiC. ZosangzualiM. TochhawngL. TrivediA.K. KumarN.S. SiamaZ. Mussaenda macrophylla Wall. exhibit anticancer activity against Dalton’s lymphoma ascites (DLA) bearing mice via alterations of redox-homeostasis and apoptotic genes expression.J. Basic Appl. Zool.2022831610.1186/s41936‑022‑00268‑9
     [Google Scholar]
  79. AktherY. NabiJ. TabassumN. Comprehensive overview of some edible medicinal plants from Kashmir Valley: Cultural, economic, and pharmacological importance. Edible Plants in Health and Diseases.SingaporeSpringer202210.1007/978‑981‑16‑4880‑9
     [Google Scholar]
  80. Mat JusohM.A.A. ArisF. Mohd JalilM.T. Ahmad KamilK. ZakariaN.A. Review of Malaysian medicinal plants with potential anticancer activity.Malays. Appl. Biol.202352113410.55230/mabjournal.v52i1.2274
     [Google Scholar]
  81. MetiV. MishraS. Pharmacological activities of Spermacoce hispida Linn: A review.Int. J. Res. Ayurveda Pharm.201341182210.7897/2277‑4343.04115
     [Google Scholar]
  82. KansoM. HijaziM. Aboul ElaM. El-LakanyA. Medicinal plants’ stress factors: Effects on metabolites and novel perspectives for tolerance.BAU J. Health Well-Being202251610.54729/XWWG9154
     [Google Scholar]
/content/journals/cbc/10.2174/0115734072373736250412081850
Loading
Study of the Phytochemistry and Anticancer Activity of Plants from Family Rubiaceae
Curr. Bioact. Compd. 22, E15734072373736 (2026); https://doi.org/10.2174/0115734072373736250412081850
/content/journals/cbc/10.2174/0115734072373736250412081850
/content/journals/cbc/10.2174/0115734072373736250412081850
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anti-cancer activity; Anti-cancer potential; bioactive compounds; medicinal plants; phytochemistry; rubiaceae

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test